SAN DIEGO--(BUSINESS WIRE)--Aug. 29, 2006--Cytori Therapeutics (NASDAQ: CYTX) (Frankfurt: XMPA) today announced it authored a review describing the emerging medical opportunity for adipose stem and regenerative cells in cosmetic and reconstructive surgery. The paper, appearing in the September 2006 supplement of Plastic & Reconstructive Surgery, reviews scientific and clinical data demonstrating the potential of adipose stem and regenerative cells in applications from elective cosmetic surgery, wrinkle therapy and breast augmentation to repair of soft tissue defects and radiation damage post mastectomy.
